{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:23:44Z","timestamp":1788881024439,"version":"build-2803163510"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The choice of optimal resuscitation fluid for patients with septic shock remains a controversial topic. The 2021 Sepsis Surviving Campaign Guidelines strongly recommend using crystalloids as the first-line resuscitation fluid for adults with sepsis or septic shock, with balanced crystalloids as a weak recommendation. However, two large-scale network meta-analyses in 2020 concluded that balanced crystalloids are most advantageous. This study reevaluates the efficacy and safety of different resuscitation fluids in septic shock through a network meta-analysis (NMA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Databases including PubMed, EMBASE, and WOS were searched, and reference lists of relevant literature up to September 2024 were reviewed. Studies involving adult patients with sepsis requiring fluid resuscitation were selected. The fluids covered include balanced crystalloid (BC), saline, iso-oncotic albumin (Iso-Alb), hyper-oncotic albumin (Hyper-Alb), low molecular weight hydroxyethyl starch (L-HES), high molecular weight hydroxyethyl starch (HES), and gelatin. A network meta-analysis was conducted to assess the effects of different fluid types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 32 RCTs were included in the analysis. The NMA probability ranking results show that balanced crystalloid (BC) had the lowest all-cause mortality rate, with the highest SUCRA value (83.1%). Gelatin was shown to confer the greatest advantage in terms of kidney injury, with the highest SUCRA value (80.7%). Hyper-oncotic albumin had the lowest occurrence of renal replacement therapy events, showing the highest SUCRA value (94.1%). Patients treated with balanced crystalloids had the shortest ICU stays and hospital lengths of stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Balanced solutions (BS) are the preferred resuscitation fluids for septic shock. High molecular weight hydroxyethyl starch (H-HES) is associated with increased risks of mortality, acute kidney injury (AKI), and renal replacement therapy (RRT), as well as prolonged hospital stays, and its use is advised against. Gelatin is associated with poorer outcomes in terms of mortality, continuous renal replacement therapy (CRRT), and length of hospital stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      Registration ID: INPLASY2024100049\n                      <jats:uri>https:\/\/doi.org\/10.37766\/inplasy2024.10.0049<\/jats:uri>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1543586","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T01:29:12Z","timestamp":1750123752000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Fluid resuscitation in adults with severe infection and sepsis: a systematic review and network meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Binglin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangrui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangde","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/ciaa059","article-title":"Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure","volume":"72","author":"Rhee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus ringer\u2019s acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.7326\/M14-0178","article-title":"Fluid resuscitation in sepsis: a systematic review and network meta-analysis","volume":"161","author":"Rochwerg","year":"2014","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations","volume":"193","author":"Fleischmann","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital-and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"CD000567","DOI":"10.1002\/14651858.CD000567.pub7","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill people","volume":"8","author":"Lewis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jcrc.2018.11.031","article-title":"Crystalloids vs. colloids for fluid resuscitation in the intensive care unit: a systematic review and meta-analysis","volume":"50","author":"Martin","year":"2019","journal-title":"J Crit Care"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e798","DOI":"10.1097\/CCM.0000000000003900","article-title":"Lactated ringer\u2019s versus 4% albumin on lactated ringer\u2019s in early sepsis therapy in cancer patients: a pilot single-center randomized trial","volume":"47","author":"Park","year":"2019","journal-title":"Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7575\/aiac.abcmed.17.05.04.02","article-title":"Albumin as a resuscitative fluid in patients with severe sepsis: a randomized clinical trial","volume":"5","author":"Kakaei","year":"2017","journal-title":"Adv Biosci Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jama.2021.11684","article-title":"Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial","volume":"326","author":"Zampieri","year":"2021","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJMoa2114464","article-title":"Balanced multielectrolyte solution versus saline in critically ill adults","volume":"386","author":"Finfer","year":"2022","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1097\/CCM.0000000000006348","article-title":"Albumin versus balanced crystalloid for the early resuscitation of sepsis: an open parallel-group randomized feasibility trial\u2014the ABC-sepsis trial","volume":"52","author":"Gray","year":"2024","journal-title":"Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03419-y","article-title":"Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses","volume":"24","author":"Tseng","year":"2020","journal-title":"Crit Care"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/SHK.0000000000001468","article-title":"Resuscitation fluids in septic shock: a network meta-analysis of randomized controlled trials","volume":"53","author":"Li","year":"2020","journal-title":"Shock"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"ED000142","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions","volume":"2019","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the five-number summary and its application in meta-analysis","volume":"32","author":"Shi","year":"2023","journal-title":"Stat Med Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"ref24","first-page":"839","article-title":"Fluid resuscitation in circulatory shock","volume":"11","author":"Rackow","year":"1983","journal-title":"Crit Care Clin"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00003246-198905000-00003","article-title":"Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion","volume":"17","author":"Rackow","year":"1989","journal-title":"Crit Care Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s001340000606","article-title":"Assessment of hemodynamic and gastric mucosal acidosis with modified fluid gelatin versus 6% hydroxyethyl starch: a prospective, randomized study","volume":"26","author":"Asfar","year":"2000","journal-title":"Intensive Care Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(00)04211-2","article-title":"Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study","volume":"357","author":"Schortgen","year":"2001","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit","volume":"350","author":"Finfer","year":"2004","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s00134-004-2278-5","article-title":"Fluid resuscitation with colloids of different molecular weight in septic shock","volume":"30","author":"Moln\u00e1r","year":"2004","journal-title":"Intensive Care Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF03040900","article-title":"Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial","volume":"116","author":"Veneman","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"ref31","first-page":"655","article-title":"The effects of hydroxyethyl starch solution in critically ill patients","volume":"72","author":"Palumbo","year":"2006","journal-title":"Minerva Anestesiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jclinane.2008.05.022","article-title":"Hemodynamic effects of 6 and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients","volume":"20","author":"Friedman","year":"2008","journal-title":"J Clin Anesth"},{"key":"ref34","first-page":"472","article-title":"The effect of different fluids on early fluid resuscitation in septic shock","volume":"20","author":"Li","year":"2008","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/BF03034053","article-title":"Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial","volume":"55","author":"Mcintyre","year":"2008","journal-title":"Can J Anesth"},{"key":"ref36","first-page":"1622","article-title":"Therapeutic influence of 20% albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial","volume":"56","author":"Dolecek","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcrc.2010.04.007","article-title":"Comparison of 6% hydroxyethyl starch 130\/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients","volume":"25","author":"Dubin","year":"2010","journal-title":"J Crit Care"},{"key":"ref38","first-page":"S115","volume-title":"Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study","author":"Charpentier","year":"2011"},{"key":"ref39","volume-title":"BaSES trial: Basel starch evaluation in sepsis","author":"Siegemund","year":"2013"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc11358","article-title":"Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130\/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study","volume":"16","author":"Guidet","year":"2012","journal-title":"Crit Care"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethyl starch or saline for fluid resuscitation in intensive care","volume":"367","author":"Myburgh","year":"2012","journal-title":"N Engl J Med."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1001\/jama.2013.280502","article-title":"Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial","volume":"310","author":"Annane","year":"2013","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.2015.12334","article-title":"Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial","volume":"314","author":"Young","year":"2015","journal-title":"JAMA"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2022.03.043","article-title":"A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]","volume":"77","author":"Maiwall","year":"2022","journal-title":"J Hepatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12072-021-10164-z","article-title":"Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial","volume":"15","author":"Philips","year":"2021","journal-title":"Hepatol Int"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1024907920948983","article-title":"0.9% saline V\/S ringer\u2019s lactate for fluid resuscitation in adult sepsis patients in emergency medical services: an open-label randomized controlled trial","volume":"29","author":"Golla","year":"2022","journal-title":"Hong Kong J Emerg Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.33192\/Smj.2020.61","article-title":"Albumin versus gelatin solution for the treatment of refractory septic shock: a patient baseline-matched-cohort study","volume":"72","author":"Tongyoo","year":"2020","journal-title":"Siriraj Med J"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.chest.2020.08.2068","article-title":"Effect of early balanced crystalloids before ICU admission on sepsis outcomes","volume":"159","author":"Jackson","year":"2021","journal-title":"Chest"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3724\/zdxbyxb-2021-0210","article-title":"Risk factors for lateral cervical lymph node metastasis in medullary thyroid carcinoma","volume":"50","author":"Wu","year":"2021","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1080\/03007995.2020.1840970","article-title":"Opinion. Phases of fluid management and the roles of human albumin solution in perioperative and critically ill patients","volume":"36","author":"Wiedermann","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jcrc.2016.04.019","article-title":"Fluid management in sepsis: the potential beneficial effects of albumin","volume":"35","author":"Vincent","year":"2016","journal-title":"J Crit Care"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/anae.14497","article-title":"Anaphylaxis to intravenous gelatin-based solutions: a case series examining clinical features and severity","volume":"74","author":"Farooque","year":"2019","journal-title":"Anaesthesia"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/SHK.0000000000000268","article-title":"Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death","volume":"43","author":"Kelm","year":"2015","journal-title":"Shock"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00134-016-4675-y","article-title":"Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database","volume":"43","author":"Marik","year":"2017","journal-title":"Intensive Care Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/anae.12661","article-title":"The endothelial glycocalyx: a review of the vascular barrier","volume":"69","author":"Alphonsus","year":"2014","journal-title":"Anaesthesia"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","article-title":"Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality","volume":"39","author":"Boyd","year":"2011","journal-title":"Crit Care Med"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/j.jvca.2024.10.021","article-title":"Protective hemodynamics: CLEAR!","volume":"39","author":"D\u2019amico","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/MCC.0000000000001205","article-title":"Protective hemodynamics: a novel strategy to manage blood pressure","volume":"30","author":"D\u2019amico","year":"2024","journal-title":"Curr Opin Crit Care"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1543586\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T01:29:14Z","timestamp":1750123754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1543586\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":60,"alternative-id":["10.3389\/fmed.2025.1543586"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1543586","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1543586"}}